Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis

被引:117
作者
Teng, S. [1 ]
Piquette-Miller, M. [1 ]
机构
[1] Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON M5S 3M2, Canada
关键词
PXR; transporters; cytochrome P450; cholestasis; bile acids; hepatotoxicity;
D O I
10.1038/sj.bjp.0707235
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Background and purpose: Activation of the pregnane X receptor ( PXR) has been shown to protect against cholestatic hepatotoxicity. As PXR alters the expression of numerous hepatic bile acid transporters, we sought to delineate their potential role in hepatoprotection. Experimental approach: Wild- type ( PXR+/+) and PXR- null ( PXR-/-) mice were fed a 1% cholic acid ( CA) diet with or without the PXR activator, PCN. Liver function was assessed along with the corresponding changes in hepatic gene expression. Key results: CA administration caused significant hepatotoxicity in PXR+/+ mice and was associated with induction of several FXR and PXR regulated genes, which encode for bile acid transport and metabolizing proteins. Compared to CA alone, coadministration of PCN to CA- fed PXR+/+ mice significantly decreased hepatotoxicity and was associated with induction of MRP3 mRNA as well as CYP3A11 mRNA and functional activity. Unexpectedly, PXR-/- mice, which expressed significantly higher basal and CA- induced levels of MRP2, MRP3, OST alpha, OST beta, OATP2 and CYP3A11, were dramatically less sensitive to CA hepatotoxicity than PXR+/+ mice. Conclusions: Protection of PXR+/+ mice against CA induced hepatotoxicity by PCN is associated with the induction of MRP3 and CYP3A11 expression. Resistance against CA- induced hepatotoxicity in PXR-/- mice may result from higher basal and induced expression of bile acid transporters, particularly MRP3. These findings emphasize the importance of transport by MRP3 and metabolism as major protective pathways against cholestatic liver injury. British Journal of Pharmacology ( 2007).
引用
收藏
页码:367 / 376
页数:10
相关论文
共 38 条
[1]
Transport activity of human MRP3 expressed in Sf9 cells: Comparative studies with rat MRP3 [J].
Akita, H ;
Suzuki, H ;
Hirohashi, T ;
Takikawa, H ;
Sugiyama, Y .
PHARMACEUTICAL RESEARCH, 2002, 19 (01) :34-41
[2]
Regulation of cholesterol 7α-hydroxylase mRNA expression in C57BL/6 mice fed an atherogenic diet [J].
Ando, H ;
Tsuruoka, S ;
Yamamoto, H ;
Takamura, T ;
Kaneko, S ;
Fujimura, A .
ATHEROSCLEROSIS, 2005, 178 (02) :265-269
[3]
Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice [J].
Assem, M ;
Schuetz, EG ;
Leggas, M ;
Sun, DX ;
Yasuda, K ;
Reid, G ;
Zelcer, N ;
Adachi, M ;
Strom, S ;
Evans, RM ;
Moore, DD ;
Borst, P ;
Schuetz, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (21) :22250-22257
[4]
OSTα-OSTβ:: A major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia [J].
Ballatori, N ;
Christian, WV ;
Lee, JY ;
Dawson, PA ;
Soroka, CJ ;
Boyer, JL ;
Madejczyk, MS ;
Li, N .
HEPATOLOGY, 2005, 42 (06) :1270-1279
[5]
Modulation of rat hepatocyte proliferation by bile salts: In vitro and in vivo studies [J].
Barone, M ;
Francavilla, A ;
Polimeno, L ;
Ierardi, E ;
Romanelli, D ;
Berloco, P ;
DiLeo, A ;
Panella, C .
HEPATOLOGY, 1996, 23 (05) :1159-1166
[6]
Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction [J].
Bertilsson, G ;
Heidrich, J ;
Svensson, K ;
Åsman, M ;
Jendeberg, L ;
Sydow-Bäckman, M ;
Ohlsson, R ;
Postlind, H ;
Blomquist, P ;
Berkenstam, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) :12208-12213
[7]
Tumor necrosis factor α-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis [J].
Bohan, A ;
Chen, WS ;
Denson, LA ;
Held, MA ;
Boyer, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (38) :36688-36698
[8]
ETHINYLESTRADIOL TREATMENT INDUCES MULTIPLE CANALICULAR MEMBRANE-TRANSPORT ALTERATIONS IN RAT-LIVER [J].
BOSSARD, R ;
STIEGER, B ;
ONEILL, B ;
FRICKER, G ;
MEIER, PJ .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2714-2720
[9]
ANALYSIS OF PLASMA BILE-ACID PROFILES IN PATIENTS WITH LIVER-DISEASES ASSOCIATED WITH CHOLESTASIS [J].
BREMMELGAARD, A ;
ALME, B .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1980, 15 (05) :593-600
[10]
Biliary bile acids in primary biliary cirrhosis: Effect of ursodeoxycholic acid [J].
Combes, B ;
Carithers, RL ;
Maddrey, WC ;
Munoz, S ;
Garcia-Tsao, G ;
Bonner, GF ;
Boyer, JL ;
Luketic, VA ;
Shiffman, ML ;
Peters, MG ;
White, H ;
Zetterman, RK ;
Risser, R ;
Rossi, SS ;
Hofmann, AF .
HEPATOLOGY, 1999, 29 (06) :1649-1654